Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carlos Richard Espiga"'
Autor:
Elena Bustamante Estebanez, Lucía Lavín Alconero, Beatriz Josa Fernández, Monica Gozalo Marguello, Juan Carlos López Caro, Jonathan Diez Vallejo, Marta Fernandez Sampedro, Pedro Muñoz Cacho, Carlos Richard Espiga, María Mar García Saiz
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background There is no strong evidence that any drug is beneficial either for the treatment of SARS-CoV-2 disease or for post-exposure prophylaxis. Therefore, clinical research is crucial to generate results and evaluate strategies against C
Externí odkaz:
https://doaj.org/article/6486479d2d3848e6a70223b270209caa
Autor:
Xavier Poiré, Myriam Labopin, Emmanuelle Polge, Edouard Forcade, Arnold Ganser, Liisa Volin, Mauricette Michallet, Didier Blaise, Ibrahim Yakoub-Agha, Johan Maertens, Carlos Richard Espiga, Jan Cornelissen, Jürgen Finke, Mohamad Mohty, Jordi Esteve, Arnon Nagler
Publikováno v:
Haematologica, Vol 105, Iss 2 (2020)
Deletion 5q or monosomy 5 (-5/5q-) in acute myeloid leukemia (AML) is a common high-risk feature that is referred to allogeneic stem cell transplantation. However, -5/5q- is frequently associated with other high-risk cytogenetic aberrations such as c
Externí odkaz:
https://doaj.org/article/c77c56fab63c4c84bf3fde39bec3f148
Autor:
Carlos Richard Espiga, Pedro Muñoz Cacho, Jonathan Diez Vallejo, Juan Carlos López Caro, Elena Bustamante Estebanez, Marta Fernandez Sampedro, Lucía Lavín Alconero, Beatriz Josa Fernández, Monica Gozalo Marguello, María Mar García Saiz
Publikováno v:
Trials
Trials, Vol 22, Iss 1, Pp 1-12 (2021)
Trials, Vol 22, Iss 1, Pp 1-12 (2021)
Background There is no strong evidence that any drug is beneficial either for the treatment of SARS-CoV-2 disease or for post-exposure prophylaxis. Therefore, clinical research is crucial to generate results and evaluate strategies against COVID-19.
Autor:
Arnold Ganser, Jan J. Cornelissen, Xavier Poiré, Ibrahim Yakoub-Agha, Mauricette Michallet, Liisa Volin, Didier Blaise, Edouard Forcade, Jürgen Finke, Jordi Esteve, Mohamad Mohty, Arnon Nagler, Myriam Labopin, Carlos Richard Espiga, Johan Maertens, Emmanuelle Polge
Publikováno v:
Haematologica, 105(2), 414-423. Ferrata Storti Foundation
Haematologica
Haematologica
Deletion 5q or monosomy 5 (-5/5q-) in acute myeloid leukemia (AML) is a common high-risk feature that is referred to allogeneic stem cell transplantation. However, -5/5q- is frequently associated with other high-risk cytogenetic aberrations such as c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4166a9643fd3709a85aac3ae0f07b1b0
http://hdl.handle.net/10138/313286
http://hdl.handle.net/10138/313286
Autor:
Gustaaf W. van Imhoff, Noel Milpied, Mauricette Michallet, Mohamad Mohty, Jean-Yves Cahn, Lucienne Michaux, Xavier Poiré, Arnon Nagler, Liisa Volin, Jan J. Cornelissen, Myriam Labopin, Carlos Richard Espiga, J. Hendrik Veelken, Ibrahim Yacoub-Agha
Publikováno v:
American Journal of Hematology, 90(8), 719-724
ResearcherID
American Journal of Hematology, 90(8), 719-724. Wiley
American Journal of Hematology, 90(8), 719-724. Wiley-Liss Inc.
ResearcherID
American Journal of Hematology, 90(8), 719-724. Wiley
American Journal of Hematology, 90(8), 719-724. Wiley-Liss Inc.
Acute myeloid leukemia with monosomal karyotype (MK AML) carries a very poor prognosis, even after allogeneic stem cell transplantation (SCT). However, SCT remains the only curative option in this high-risk population. Because myeloablative condition
Autor:
Mercedes Colorado, Miguel A. Piris, Guillermo Martín-Sánchez, Ana Batlle, Sonia González de Villambrosia, María Pané-Foix, Eulogio Conde, Santiago Montes-Moreno, Andrés Insunza, Fina Climent, Carlos Richard Espiga, Eva M González Barca
Publikováno v:
Histopathology. 67(6)
Aims Here we report two cases of follicular lymphoma that transformed to CD30 positive diffuse large B cell lymphoma and review the literature on this topic. Results The first case represents an example of early transformation of conventional low-gra
Autor:
Gudrun Göhring, Patrice Chevallier, Nicolaus Kröger, Jean-Henri Bourhis, Liisa Volin, Marie Robin, Didier Blaise, Jakob Passweg, Noel Milpied, Dimitris Ziagkos, Theo de Witte, Anja van Biezen, Johannes Schetelig, Nigel H. Russell, Jan J. Cornelissen, Charles Craddock, Ibrahim Yakoub-Agha, Ghulam J. Mufti, Liesbeth C. de Wreede, Jürgen Finke, Carlos Richard Espiga, Per Ljungman, Tobias Gedde-Dahl, Michel Schaap, Johan Maertens, Hein Putter
Publikováno v:
ResearcherID
Web of Science
Web of Science
Introduction The number of MDS patients who receive allogeneic stem cell transplantation is steadily increasing. However, the main cause for treatment failure is relapse which exceeds 50%. Post transplant strategies such as novel agents (5-azacytidin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35a25822a750980b5c74b1312ebc610c
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000394452507156&KeyUID=WOS:000394452507156
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000394452507156&KeyUID=WOS:000394452507156